[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechNewswire The Biotech Newswire The Biotech Newswire posts on X about $8750t, $4568t, $6417t, $heide the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::27646691/interactions)  - X Week XXX -XXXX% - X Month XXX +4,325% - X Months XXX +185% - X Year XXXXX -XX% ### Mentions: X [#](/creator/twitter::27646691/posts_active)  - X Week X no change - X Month XX +1,000% - X Months XX +140% - X Year XX no change ### Followers: XXXXX [#](/creator/twitter::27646691/followers)  - X Week XXXXX -XXXX% - X Month XXXXX -XXXX% - X Months XXXXX -XXXX% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::27646691/influencer_rank)  ### Social Influence [#](/creator/twitter::27646691/influence) --- **Social topic influence** [$8750t](/topic/$8750t) #18, [$4568t](/topic/$4568t) #3, [$6417t](/topic/$6417t) #7, [$heide](/topic/$heide) #80, [targets](/topic/targets) #1218 ### Top Social Posts [#](/creator/twitter::27646691/posts) --- Top posts by engagements in the last XX hours "New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX @EUdaiichisankyo" [X Link](https://x.com/BiotechNewswire/status/1981208966035333345) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T04:00Z 4342 followers, XX engagements "New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX" [X Link](https://x.com/BiotechNewswire/status/1981314666698592332) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T11:00Z 4342 followers, XX engagements "New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology" [X Link](https://x.com/BiotechNewswire/status/1981375065519174123) [@BiotechNewswire](/creator/x/BiotechNewswire) 2025-10-23T15:00Z 4342 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechNewswire The Biotech NewswireThe Biotech Newswire posts on X about $8750t, $4568t, $6417t, $heide the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Social topic influence $8750t #18, $4568t #3, $6417t #7, $heide #80, targets #1218
Top posts by engagements in the last XX hours
"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX @EUdaiichisankyo"
X Link @BiotechNewswire 2025-10-23T04:00Z 4342 followers, XX engagements
"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology #BioMedX"
X Link @BiotechNewswire 2025-10-23T11:00Z 4342 followers, XX engagements
"New Research Team for Multispecific Biologics in Collaboration with Daiichi Sankyo Starts at the BioMed X Institute in Heidelberg. Research targets innovative pathways in the tumor microenvironment (TME) #biotech #Oncology"
X Link @BiotechNewswire 2025-10-23T15:00Z 4342 followers, XX engagements
/creator/x::BiotechNewswire